Efficacy and safety results from a phase Ⅲ trial of nivolumab (NIVO) alone or combined with ipilimum - 论文文献免费下载 - 皮皮文库

Efficacy and safety results from a phase Ⅲ trial of nivolumab (NIVO) alone or combined with ipilimum

来源 :2015年临床肿瘤学新进展学术研讨会 | 被引量 : 0次 | 上传用户：colawind

【作者】

：

Jedd D. Wolchok Vanna Chiarion-Sileni Rene Gonzalez Piotr Rutkowski Jean Jacques Grob Charles Lance Cowey Christopher D. Lao Dirk Schadendorf Pier Francesco Ferrucci Michael Smylie Reinhard Dummer And

【机构】

：

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

【出处】

：

2015年临床肿瘤学新进展学术研讨会

【发表日期】

：

2015年3期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Successful implementation of a novel trial model: The Signature program.

会议

A pharmacokinetically (PK) and pharmacodynamically (PD) driven phase I trial of the pan-AKT inhibito

会议

A phase I study of PF-05082566 (anti-4-1BB) + rituximab in patients with CD20+ NHL

会议

Phase Ⅱ multicenter proof of concept study of AZD4547 in FGFR amplified tumours

会议

Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma

会议

Efficacy based on tumor PD-L1 expression in KEYNOTE-002, a randomized comparison of pembrolizumab (p

会议

GADOLIN: Primary results from a phase Ⅲ study of obinutuzumab plus bendamustine compared with bendam

会议

Phase Ⅱ study of daratumumab (DARA) monotherapy in patients with ≥ 3 lines of prior therapy or doubl

会议

ELOQUENT-2: A phase Ⅲ, randomized, open-label study of lenalidomide (Len)/dexamethasone (dex) with/w

会议

Phase Ⅱa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patie

会议

其他学术论文